Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis – A pooled analysis

Chronic hepatitis C virus (HCV) infection is characterized by progressive liver damage and fibrosis, which can lead to liver failure or hepatocellular carcinoma.1 In 2013, an estimated 357,800 people worldwide died from HCV-related cirrhosis, and an additional 342,500 people died from liver cancer caused by HCV.2 The burden of HCV-associated liver disease is projected to continue to increase in many countries in the coming decades.3

Source: Journal of Hepatology - June 20, 2017 Category: Gastroenterology Authors: Fred Poordad, David R. Nelson, Jordan J. Feld, Michael W. Fried, Heiner Wedemeyer, Lois Larsen, Daniel E. Cohen, Eric Cohen, Niloufar Mobashery, Fernando Tatsch, Graham R. Foster Tags: Research Article Source Type: research